Literature DB >> 1937833

Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection.

K Bromberg1, G Tannis, P Steiner.   

Abstract

In humans, infection with Bordetella pertussis is considered to be localized to an epithelial surface. However, an intracellular state in cultured cells and in the macrophages of infected animals has been shown. By using indirect immunofluorescence with a monoclonal antibody, it was found that 3 of 20 bronchoalveolar lavage specimens from children with human immunodeficiency virus infection had B. pertussis associated with pulmonary alveolar macrophages. None of the cultures from the patients grew B. pertussis. The B. pertussis appeared to be intracellular.

Entities:  

Mesh:

Year:  1991        PMID: 1937833      PMCID: PMC259105          DOI: 10.1128/iai.59.12.4715-4719.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Distribution of concanavalin A in fibroblasts: direct endocytosis versus surface capping.

Authors:  B Storrie; P J Edelson
Journal:  Cell       Date:  1977-07       Impact factor: 41.582

2.  Invasion of HeLa 229 cells by virulent Bordetella pertussis.

Authors:  C A Ewanowich; A R Melton; A A Weiss; R K Sherburne; M S Peppler
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Unexpected isolation of Bordetella pertussis from patients with acquired immunodeficiency syndrome.

Authors:  V L Ng; M York; W K Hadley
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

4.  Pertussis in a previously immunized child with human immunodeficiency virus infection.

Authors:  P C Adamson; T C Wu; B D Meade; M Rubin; C R Manclark; P A Pizzo
Journal:  J Pediatr       Date:  1989-10       Impact factor: 4.406

5.  Macrophage behaviour during the complaisant phase of murine pertussis.

Authors:  C Cheers; D F Gray
Journal:  Immunology       Date:  1969-12       Impact factor: 7.397

6.  Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.

Authors:  Z M Li; J L Cowell; M J Brennan; D L Burns; C R Manclark
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

7.  Use of erythromycin in pertussis outbreaks.

Authors:  J W Bass
Journal:  Pediatrics       Date:  1983-11       Impact factor: 7.124

8.  Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization.

Authors:  K Saukkonen; C Cabellos; M Burroughs; S Prasad; E Tuomanen
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

9.  Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells.

Authors:  E Tuomanen; H Towbin; G Rosenfelder; D Braun; G Larson; G C Hansson; R Hill
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

  9 in total
  30 in total

1.  Phagocytosed Bordetella pertussis fails to survive in human neutrophils.

Authors:  D H Lenz; C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

3.  Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes.

Authors:  L L Steed; E T Akporiaye; R L Friedman
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

4.  Intracellular trafficking of Bordetella pertussis in human macrophages.

Authors:  Yanina A Lamberti; Jimena Alvarez Hayes; Maria L Perez Vidakovics; Eric T Harvill; Maria Eugenia Rodriguez
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

5.  Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children.

Authors:  M Ryan; G Murphy; E Ryan; L Nilsson; F Shackley; L Gothefors; K Oymar; E Miller; J Storsaeter; K H Mills
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

6.  Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine.

Authors:  F Zepp; M Knuf; P Habermehl; J H Schmitt; C Rebsch; P Schmidtke; R Clemens; M Slaoui
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

7.  Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells.

Authors:  C A Guzman; M Rohde; M Bock; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Virulence of Bordetella bronchiseptica: role of adenylate cyclase-hemolysin.

Authors:  P Gueirard; N Guiso
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Bordetella pertussis infection of primary human monocytes alters HLA-DR expression.

Authors:  Jennifer A Shumilla; Vashti Lacaille; Tara M C Hornell; Jennifer Huang; Supraja Narasimhan; David A Relman; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.